Ohashi, H.; Wang, F.; Stappenbeck, F.; Tsuchimoto, K.; Kobayashi, C.; Saso, W.; Kataoka, M.; Yamasaki, M.; Kuramochi, K.; Muramatsu, M.;
et al. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro. Int. J. Mol. Sci. 2021, 22, 3163.
https://doi.org/10.3390/ijms22063163
AMA Style
Ohashi H, Wang F, Stappenbeck F, Tsuchimoto K, Kobayashi C, Saso W, Kataoka M, Yamasaki M, Kuramochi K, Muramatsu M,
et al. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro. International Journal of Molecular Sciences. 2021; 22(6):3163.
https://doi.org/10.3390/ijms22063163
Chicago/Turabian Style
Ohashi, Hirofumi, Feng Wang, Frank Stappenbeck, Kana Tsuchimoto, Chisa Kobayashi, Wakana Saso, Michiyo Kataoka, Masako Yamasaki, Kouji Kuramochi, Masamichi Muramatsu,
and et al. 2021. "Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro" International Journal of Molecular Sciences 22, no. 6: 3163.
https://doi.org/10.3390/ijms22063163
APA Style
Ohashi, H., Wang, F., Stappenbeck, F., Tsuchimoto, K., Kobayashi, C., Saso, W., Kataoka, M., Yamasaki, M., Kuramochi, K., Muramatsu, M., Suzuki, T., Sureau, C., Takeda, M., Wakita, T., Parhami, F., & Watashi, K.
(2021). Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro. International Journal of Molecular Sciences, 22(6), 3163.
https://doi.org/10.3390/ijms22063163